Zdrowie i gospodarka · 22/04/2026
FDA Classifies Digital Therapy Device for Amblyopia into Class II
The FDA has classified the digital therapy device for amblyopia into Class II, a move aimed at ensuring the device's safety and effectiveness while reducing regulatory burdens and enhancing patient access.